Prostate Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Prostate Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Multicenter Trial of ESK981 in Patients With Select Solid Tumors [Phase 2]
This document reports a Phase 2 multicenter clinical trial of ESK981 in select solid tumors. The study is currently recruiting across specif…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells [Phase 2]
A Phase 2 clinical trial is evaluating the safety and effectiveness of Lutetium-177 dotatate for metastatic prostate cancer with neuroendocr…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial update describing a chemoimmunotherapy study for men with metastatic prostate cancer, including neuroendocrine and …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]
Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer [Phase 2]
This Phase 2 trial evaluates cabazitaxel, carboplatin, and cetrelimab with or without niraparib for aggressive variant metastatic prostate c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT [Phase 1]
Phase 1 pilot study to detect PSMA-low castration-resistant prostate cancer with Fluciclovine PET/CT; trial is currently recruiting.